Sunlight Omnisense 8000 – Adults Configuration
Sunlight Omnisense™ 8000
The portable Sunlight Omnisense™ 8000 Quantitative Ultrasound is a portable Bone Sonometer that enables physicians to provide early assessment, and monitoring of osteoporosis in any patient, with ultimate ease and convenience. Offering radiation-free bone density measurement, the Omnisense 8000 is highly reliable, accurate, non-invasive and safe for patients and clinicians.
The Omnisense 8000 is part of the Sunlight family of Omnipath™-based solutions. Proven in thousands of installations worldwide, Omnisense systems are the first – and currently only – multi-site* ultrasound devices available today that allow first-line early assessment, diagnosis and monitoring of osteoporosis.
Bone Density Assessment for Any Patient, Anywhere
Omnisense 8000 is ideal for managing and monitoring osteoporosis diagnosis and treatment for any patient. As a portable, standalone device, it can easily be used by physicians who work in multiple locations and by medical centers with mobility needs, walk-in clinics and pharmacies. It uses different software modules and four ethnical clinical reference databases, making it suitable for patients aged 0-99 years, including neonates.
The Omnisense 8000 Advantage
- Compact and Portable
- Standalone system
- Portable, lightweight and easy to carry
- Proven safety
- High accuracy
- Precise measurements – a unique multi-site measurement option*
- Utilizes market-proven Omnipath technology
- Fast Results
- WHO-compliant T-score and Z-score results
- Easy to understand, graphical measurement report created within minutes
- Easy to learn and use
- Includes complete training support with a practice mode and training video.
- Built-in patient data management
- Printed report includes patient details and measurement history
- Low system cost
- No disposables
- Compact, standalone device
- Smaller than an average desktop computer
- Advanced capabilities
- Suitable for 0 – 99 years
- Supports Sunlight PREMIER software for bone density assessment in premature babies
- Supports Sunlight Pediatric software accurate bone density assessment of children aged 0-18 years
- Dedicated software for adults enables accurate bone density assessment for people aged 19 – 99 years
- Can be connected to Sunlight Tetrax and BonAge devices for expanded applications
- Easy import/export of data from/to other Omnisense systems
- Data is easily exported to Microsoft Excel (optional)
Includes selectable ethnic male and female reference databases
* Please note that the following features have not yet been approved by the US FDA:
- Measurement at the Tibia bone
- Combining measurement results of different skeletal sites
Sunlight Omnisense 8000 – Pediatric Configuration
BonAge Pediatric – Bone density and growth assessment software for children
Sunlight Pediatric software offers a unique, radiation-free solution to the challenge of safely and accurately assessing bone density in children. Designed specifically for use with pediatric patients aged 0 – 18 years, Sunlight Pediatric works with any of the Sunlight range of bone sonometers – Sunlight Omnisense™ 7000, Omnisense 8000, and MiniOmni™. Quick and easy to use, Sunlight Pediatric software provides the physician with an accurate bone strength evaluation.
Helping Children Reach their Potential
Sunlight Pediatric was developed in response to the growing need to measure and monitor children during their critical growth years. Research indicates that inadequate physical activity and poor nutrition can compromise bone development and lead to fractures even among otherwise healthy children. This can in turn lead to poor skeletal health and osteoporosis later in life.
With Sunlight Pediatric, children with known risk factors such as poor nutritional habits, eating disorders, sedentary lifestyles, and premature birth or low birth weight have access to bone strength assessment. With measurements performed using a Sunlight bone sonometer, the software can provide an early warning of inadequate bone strength development, giving children a head start in working towards reaching their peak bone mass.
Featuring patented Omnipath™ technology and working with the Sunlight bone sonometers, Sunlight Pediatric automatically compares speed of sound measurements to a unique built-in reference database of healthy children ages 0-18. Results are expressed as age- and gender-matched Z-scores and percentiles. All results are presented in a graphical report that can be stored or printed. The software includes patient history and scheduling features which enable easy tracking of measurement history.
*** Please note that the BonAge has not yet been approved by the FDA.
Sunlight Omnisense 8000 – Neonatal Configuration
Neonatal bone growth assessment software for premature babies
Sunlight PREMIER software offers the first – and currently only – radiation-free method available for the safe and accurate bone growth assessment of pre-term infants. The widespread prevalence of osteopenia of prematurity (OOP) among pre-term infants makes Sunlight PREMIER an essential and unique tool in hospital neonatal units.
The Need for Pre-term Bone Growth Assessment
Pre-term babies do not achieve the bone mass normally accreted during the third trimester of pregnancy, and are often born with low bone mineralization. Days or weeks spent in neonatal intensive care units further slow their bone development.
Using Sunlight PREMIER software, which features patented Omnipath™ technology and works with Sunlight Omnisense™ 7000 and Sunlight Omnisense 8000 bone sonometers, medical professionals can measure neonates’ bones, to identify babies whose bones are underdeveloped.
Tracking Bone Growth
Sunlight PREMIER automatically compares speed of sound measurements to a built-in unique reference database which portrays the intrauterine development and bone growth curve of healthy bone.
Working with the compact and user-friendly Sunlight Omnisense bone sonometers, Sunlight PREMIER enables non-invasive and radiation-free measurement of bone, permitting safe frequent monitoring of premature infants’ bones. The extremely low margin of error provides sensitivity to each small change in the bone, enabling medical professionals to gain valuable comparative information even from daily measurements.
*** Please note that the neonatal application has not yet been approved by US FDA.